drugset / Trial / NCT00377832

Acetaminophen for Fetal Tachycardia: a Randomized Pilot Trial

NCT00377832 ↗

RandomizedParallel-groupOpen-labelTreatment

Summary

The most common cause of fetal tachycardia is maternal fever. Fetal tachycardia often precedes the maternal fever, and fetal tachycardia confounds the interpretation of electronic fetal monitoring (EFM), increasing the rate of cesarean delivery for non-reassuring fetal status (NRFS). Our hypothesis is that treatment of fetal tachycardia with acetaminophen will significantly lower maternal body temperature and significantly lower baseline fetal heart rate (FHR). The importance is that interpretation of EFM will improve, thus allowing for a decrease in cesarean delivery for NRFS.

Timeline

Start
2007-07
Primary completion
2010-12
Completion
2010-12

Outcome

Outcome not reported

Stopped (Enrollment): “Poor recruitment and lack of funding”

Drugs

EvaluationDrugModalityDoseRoute
Comparator Acetaminophen Small molecule 975 mg Oral

Indications

No indication recorded.